MagnetOs™ – Osteoinductive bone substitute
Kuros Biosciences is a global innovation company headquartered in Switzerland with a combined 150 years of research experience in the field of biologic spinal fusion products.
MagnetOs™ is an innovative bone graft, it promotes bone growth even in soft tissue thanks to the exclusive surface technology NeedleGrip™. This technology provides traction for key “healing-promoting” immune cells in the body (M2 macrophages).* 6
6. Duan, et al. eCM. 2019;37:60-73.
MagnetOs™ has been shown to be equivalent to the gold standard of autograft for spinal fusions.8-10 To date, it has been successfully used in more than 15,000 spinal fusion surgeries and is supported by an unprecedented combination of scientific, preclinical studies and clinicians through Project Fusion: our global research program, where science and clinical evidence meet.
8. Van Dijk, et al. J Biomed Mater Res. Part B: Appl Biomater. 2019;107(6):2080-2090.
10. Van Dijk, et al. Clin Spine Surg. 2020;33(6):E276-E287.
Two Versions of MagnetOs™ to meet every clinical need.
Download catalogue
